Relative influence of age and thrombotic history on hemostatic parameters

Thrombosis Research

Volumn 91, Issue 5, 1998, Pages 241-248

  Javorschi, S ^a   Richard Harston, S ^b   Labrouche, S ^a   Manciet, G ^b   Freyburger, G ^a  

^a HÔPITAL PELLEGRIN   (France)

^b Ctr Geriatrie Ctr Hosp Univ B   (France)

Author keywords

Aging; Hemostasis; Inflammation; Thrombosis

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 8C; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S; THROMBIN ANTITHROMBIN COMPLEX; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; BLOOD CELL COUNT; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ECHOGRAPHY; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PHLEBOGRAPHY; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; CHILD; FEMALE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; THROMBOSIS;

EID: 0032168810     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00104-2     Document Type: Article

References (25)

1. Hamilton P.J., Allardyce M., Ogstn D., Dawson A.A., Douglas A.S. The effect of age upon the coagulation system. J Clin Pathol. 27:1974;980-982.
2. Balleisen L., Bailey J., Epping P.H., Schutle H., Van de Loo J. Epidemiological study on factor VII, factor VIII, and fibrinogen in an industrial population, I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill using, and menopause Thromb Haemost. 54:1985;475-479.
3. Aillaud M.F., Pignol F., Alessi M.C., Harle J.R., Escande M., Mongin M., Juhan-Vague I. Increase in plasma concentration of plasminogen activator inhibitor, fibrinogen, von Willebrand factor, factor VIIIc and erythrocyte sedimentation rate with age. Thromb Haemost. 55:1986;330-332.
4. Bauer K.A., Weiss L.M., Sparrow D., Vokonas P.S., Rosenberg R.D. Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative aging study. J Clin Invest. 80:1987;1527-1534.
5. Folsom A., Wu K., Davis C., Conlan M., Sorlie P., Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis. 91:1991;191-205.
6. Tracy R.P., Bovill E.G. Thrombosis and cardiovascular risk in the elderly. Arch Pathol Lab Med. 116:1992;1307-1312.
7. Tracy R.P., Bovill E.G., Fried L.P., Heiss G., Lee M.H., Polak J.F., Psaty B.M., Savage P.J. The distribution of coagulation factors VII, VIII, and fibrinogen in adults over the age of 65 years. Results from the Cardiovascular Health Study Ann Epidemiol. 2:1992;509-519.
8. Lowe G.D., Rumley A., Woodward M., Morrisson C.E., Philippou H., Lane D.A., Tunstall-Pedoe H. Epidemiology of coagulation factors, inhibitors and activation markers. The Third Glasgow MONICA survey. I. Illustrative references ranges by age, sex and hormone use Br J Haematol. 4:1997;775-784.
9. Hamsten A., Blombäck M., Wiman B., Svensson J., Szamosi A., de Faire U., Mettinger L. Hemostatic function in myocardial infarction. Br Heart J. 55:1986;58-66.
10. Meade T.W., Mellows S., Brozovic M., Miller G.J., Chakrabarti R.R., North W.R., Haines A.P., Stirling Y., Imeson I.D., Thompson S.G. Hemostatic function and ischaemic heart disease. Principal results of the Northwick Park Heart Study Lancet. 9:1986;533-537.
11. Kannel W.B., Wolf P.A., Castelli W.P., d'Agostino R.B. Fibrinogen and risk of cardiovascular disease; the Framingham Study. JAMA. 258:1987;1183-1186.
12. Hamsten A., de Faire U., Walldius G., Dahlen G., Szamosi A., Landou C., Blombäck M., Wiman B. Plasminogen activator inhibitor in plasma. Risk factor for recurrent myocardial infarction Lancet. 2:1987;3-9.
13. Zoller B., Dahlbäck B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet. 344:1994;1536-1538.
14. Juhan-Vague I., Aillaud M.F., De Cock F., Joet P., Arnaud C., Serradigmigni A., Collen D. The fast acting inhibitor of tissue type plasminogen activator is an acute phase reactant. Davidson J.F., Donati M.B., Cocchzeri S. Progress in Fibrinolysis. 1985;146-149 Churchill Livingstone, Edinburgh.
15. Juhan-Vague I., Pyke S.D.M., Alessi M.C., Jespersen J., Haverkate F., Thompson S.G. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation. 94:1996;2057-2063.
16. Pottinger B.E., Read R.C., Paleolog E.M., Higgins P.G., Pearson J.D. Von Willebrand Factor is an acute phase reactant in man. Thromb Res. 53:1989;387-394.
17. Rapaport S.I. The extrinsic pathway inhibitor. A regulator of tissue factor dependent blood coagulation Thromb Haemost. 66:1991;6-15.
18. Wiman B. Plasminogen activator inhibitor 1 (PAI-1) in plasma. Its role in thrombotic disease Thromb Haemost. 74:1995;71-76.
19. Kannel W.B., Anderson K., Wilson P.W.F. White blood cell count and cardiovascular disease. Insights from the Framingham Study JAMA. 267:1992;1253-1256.
20. Bovill E.G., Bild D.E., Heiss G., Kuller L.H., Lee M.H., Rock R., Wahl P. White blood cell counts in persons aged 65 years or more from the Cardiovascular Health Study. Am J Epidemiol. 143:1996;1107-1115.
21. Dahlbäck B., Carlsson M., Svensson P. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C. Prediction of a cofactor to activated protein C Proc Natl Acad Sci USA. 90:1993;1004-1008.
22. Press R.D., Liu X.Y., Beamer N., Coull B.M. Ischemic stroke in the elderly. Role of the common factor V mutation causing resistance to activated protein C Stroke. 27:1996;44-48.
23. Ridker P.M., Hennekens C.H., Lindpaintner K., Stampfer M.J., Eisenberg P.R., Miletich J.P. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 332:1995;912-917.
24. Hille E.T.M., Koster T., Rosendaal F.R., Vandenbroucke J.P. Life expectancy in parents of patients with activated protein C resistance. Abstract 1811. XVth Congress of the ISTH, Jerusalem, Israel. Thromb Haemost. 73:1995;1373.
25. Stuart J. The acute phase reaction and hematological stress syndrome in vascular disease. Int J Microcirc Clin Exp 1984; p. 115-204.